Kyverna Therapeutics
KYTX
KYTX
88 hedge funds and large institutions have $240M invested in Kyverna Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
-2
Holders Change %
-2.22%
% of All Funds
1.28%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
28
Increased
34
Reduced
12
Closed
30
Calls
$48K
Puts
$102K
Net Calls
-$54K
Net Calls Change
+$455K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$15.5M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$13.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$7.62M |
| 4 |
BlackRock
New York
|
$10.9M |
| 5 |
DM
Deerfield Management
New York
|
$14.9M |
